GenePlanet

📍 Ljubljana Šentvid, Slovenia🗓 Founded 2008👥 168 employees💰 Last funded Jul 2026
Biotechnology Research🌐 geneplanet.com
Website LinkedIn
GenePlanet is the leading European provider of preventive genetic tests, specialising in NIPT, cancer screening, and lifestyle DNA tests.   With over 18 years of experience in the market, GenePlanet collaborates with over 5000 medical centres, doctors, and insurance companies to provide top-quality tests based on the latest scientific discoveries. The company’s tests are designed to empower individuals to take control of their and their baby’s health, as well as assist doctors with therapeutic procedures. GenePlanet adheres to the highest standards of quality and is constantly striving for new discoveries through its research and development efforts. With a presence in more than 50 countries worldwide and over 500.000 satisfied customers, GenePlanet has been recognised as one of the 1000 fastest-growing companies in the EU by the Financial Times and one of the Top 35 EU Unicorns by the European Commission.
2
Total investors
1
Early stage
0
Mid stage
0
Late stage
2008
Founded

Investors

2 investors
All
Early stage
Mid stage
Late stage
Investor geography2 countries
Austria
1
United States
1
Frequently asked questions
Who invested in GenePlanet?
GenePlanet has 2 investors on record on gritt.io, including 1 early-stage backers.
When did GenePlanet last raise funding?
The most recent investment in GenePlanet recorded on gritt.io was in July 2026.
When was GenePlanet founded?
GenePlanet was founded in 2008.
What industry is GenePlanet in?
GenePlanet operates in Biotechnology Research. Find similar Biotechnology Research investors on gritt.io.
Where is GenePlanet based?
GenePlanet is headquartered in Ljubljana Šentvid, Slovenia.